Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Maria L. Bertolaccini"'
Autor:
Kazuko Kobayashi, Makoto Kishi, Tatsuya Atsumi, Maria L. Bertolaccini, Hirofumi Makino, Nobuo Sakairi, Itaru Yamamoto, Tatsuji Yasuda, Munther A. Khamashta, Graham R.V. Hughes, Takao Koike, Dennis R. Voelker, Eiji Matsuura
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 4, Pp 716-726 (2003)
β2-glycoprotein I (β2-GPI) is a major antigen for antiphospholipid antibodies (Abs, aPL) present in patients with antiphospholipid syndrome (APS). We recently reported (J. Lipid Res., 42: 697, 2001; J. Lipid Res., 43: 1486, 2002) that β2-GPI speci
Externí odkaz:
https://doaj.org/article/0164a5f6c85e4caebf18c4d8e4410e83
Autor:
Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, Ann E Clarke, Maria G Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte, H. Michael Belmont, Maria Gerosa, Paul R Fortin, Chary Lopez-Pedrera, Tatsuya Atsumi, Zhouli Zhang, Hannah Cohen, Guilherme Ramires de Jesús, David W Branch, Denis Wahl, Laura Andreoli, Esther Rodriguez-Almaraz, Michelle Petri, Giuseppe Barilaro, Yu Zuo, Bahar Artim-Esen, Rohan Willis, Rosana Quintana, Margarete BG Vendramini, Megan W Barber, Maria L Bertolaccini, Robert Roubey, Doruk Erkan
Publikováno v:
Lupus. 31:1770-1776
Background/Purpose APS ACTION Registry was created to study the outcomes of patients with persistently positive antiphospholipid antibodies (aPL) with or without other systemic autoimmune disease (SAIDx). Given that immunosuppression (IS) is used for
Autor:
Hannah, Cohen, Beverley J, Hunt, Maria, Efthymiou, Deepa R J, Arachchillage, Ian J, Mackie, Simon, Clawson, Yvonne, Sylvestre, Samuel J, Machin, Maria L, Bertolaccini, Maria, Ruiz-Castellano, Nicola, Muirhead, Caroline J, Doré, Munther, Khamashta, David A, Isenberg
Publikováno v:
The Lancet. Haematology. 3(9)
Rivaroxaban is established for the treatment and secondary prevention of venous thromboembolism, but whether it is useful in patients with antiphospholipid syndrome is uncertain.This randomised, controlled, open-label, phase 2/3, non-inferiority tria
The antiphospholipid syndrome (Hughes syndrome) is now over a quarter of a century old. Although most of the major clinical features were described in the original papers between 1983 and 1985, the ensuing 25 years have seen a filling out of the clin
Autor:
Giovanni, Sanna, Maria L, Bertolaccini, Maria J, Cuadrado, Hana, Laing, Munther A, Khamashta, Alessandro, Mathieu, Graham R V, Hughes
Publikováno v:
The Journal of rheumatology. 30(5)
To apply the new American College of Rheumatology nomenclature for neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalence of the different neuropsychiatric (NP) syndromes, and evaluate which of these manifestations correlates